相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin
Hongde Hu et al.
EUROPEAN HEART JOURNAL (2021)
CD2 CR: Co-reference Resolution Across Documents and Domains
James Ravenscroft et al.
16TH CONFERENCE OF THE EUROPEAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (EACL 2021) (2021)
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Jin-jin Zhang et al.
ALLERGY (2020)
Structure analysis of the receptor binding of 2019-nCoV
Yun Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Aiping Wu et al.
CELL HOST & MICROBE (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
Shuai Xia et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
SARS-CoV-2: a potential novel etiology of fulminant myocarditis
Chen Chen et al.
HERZ (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Philippe Colson et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China
David S. Hui et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
Xintian Xu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-A Living Working Document
Keshava Rajagopal et al.
ASAIO JOURNAL (2020)
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
Kui Liu et al.
CHINESE MEDICAL JOURNAL (2020)
Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study
Yan Deng et al.
CHINESE MEDICAL JOURNAL (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
Bo Li et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19
Alina Hua et al.
EUROPEAN HEART JOURNAL (2020)
First case of COVID-19 complicated with fulminant myocarditis: a case report and insights
Jia-Hui Zeng et al.
INFECTION (2020)
How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital
Jie Zeng et al.
INTENSIVE CARE MEDICINE (2020)
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Jing Yang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
Graziano Onder et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Atrial Fibrillation in COVID-19: From Epidemiological Association to Pharmacological Implications
Vincenzo Russo et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis
Giuseppe Lippi et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
James H. Diaz
JOURNAL OF TRAVEL MEDICINE (2020)
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Mandeep R Mehra et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Lei Fang et al.
LANCET RESPIRATORY MEDICINE (2020)
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
Riccardo M. Inciardi et al.
JAMA CARDIOLOGY (2020)
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo et al.
JAMA CARDIOLOGY (2020)
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
Juyi Li et al.
JAMA CARDIOLOGY (2020)
Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort
Pierpaolo Di Micco et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series
Pavan K. Bhatraju et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study
Vincenzo Russo et al.
PHARMACOLOGICAL RESEARCH (2020)
Fourth universal definition of myocardial infarction (2018)
Kristian Thygesen et al.
EUROPEAN HEART JOURNAL (2019)
Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis
Benjamin Castagne et al.
PLOS ONE (2019)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Statin drug interactions and related adverse reactions: an update
Stefano Bellosta et al.
EXPERT OPINION ON DRUG SAFETY (2018)
The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases
Xiao C. Li et al.
PHARMACOLOGICAL RESEARCH (2017)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient
Pierangelo Chinello et al.
PLoS Neglected Tropical Diseases (2017)
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence
Vincenzo Russo et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2017)
Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus
Tariq Alhogbani
ANNALS OF SAUDI MEDICINE (2016)
Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
Alaa Badawi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
Structure, Function, and Evolution of Coronavirus Spike Proteins
Fang Li
ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)
Lack of effect of favipiravir, a novel antiviral agent, on the QT interval in healthy Japanese adults
Yuji Kumagai et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
Yaseen Arabi et al.
SPRINGERPLUS (2015)
The mercurial nature of neutrophils: still an enigma in ARDS?
Andrew E. Williams et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Alida L. P. Caforio et al.
EUROPEAN HEART JOURNAL (2013)
Chloroquine cardiotoxicity mimicking connective tissue disease heart involvement
Andras Vereckei et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2013)
Chloroquine cardiomyopathy - a review of the literature
Ernst Toennesmann et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2013)
Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure
Mark C. Genovese et al.
JOURNAL OF RHEUMATOLOGY (2013)
The MOGE(S) Classification for a Phenotype-Genotype Nomenclature of Cardiomyopathy
Eloisa Arbustini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
Cem Gabay et al.
LANCET (2013)
Arrhythmias in Fabry Cardiomyopathy
Deepak Acharya et al.
CLINICAL CARDIOLOGY (2012)
Inhibition of cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy
Andrea Frustaci et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Cardiomyopathy Caused by Longterm Treatment with Chloroquine: A Rare Disease, or a Rare Diagnosis?
Ernst Toennesmann et al.
JOURNAL OF RHEUMATOLOGY (2012)
Chloroquine-Induced Transition From Dilated to Restrictive Cardiomyopathy
Maurizio Pieroni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Electrocardiogram Abnormalities with Atazanavir and Lopinavir/Ritonavir
R. Chris Rathbun et al.
HIV CLINICAL TRIALS (2009)
Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine
Philippe Stas et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
Human immunopathogenesis of severe acute respiratory syndrome (SARS)
Mark J. Cameron et al.
VIRUS RESEARCH (2008)
Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases
N. Costedoat-Chalumeau et al.
RHEUMATOLOGY (2007)
Essential role for collectrin in renal amino acid transport
Ursula Danilczyk et al.
NATURE (2006)
Time-dependent interaction between lopinavir/ritonavir and fexofenadine
Rolf P. G. van Heeswijk et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS
J. K. Yang et al.
DIABETIC MEDICINE (2006)
Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities
C Biot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Angiotensin-converting enzyme 2 in lung diseases
Keiji Kuba et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters
A. Wozniacka et al.
LUPUS (2006)
ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia
HP Jia et al.
JOURNAL OF VIROLOGY (2005)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
CM Ferrario et al.
CIRCULATION (2005)
Chloroquine-induced cardiomyopathy-echocardiographic features
TZ Naqvi et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Treatment of severe acute respiratory syndrome
ST Lai
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
YOY Soo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
ACE2: from vasopeptidase to SARS virus receptor
AJ Turner et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways
YQ Ding et al.
JOURNAL OF PATHOLOGY (2004)
The SARS-CoV S glycoprotein: expression and functional characterization
XD Xiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Induced QT prolongation and torsades de pointes
YG Yap et al.
HEART (2003)
Angiotensin-converting enzyme 2 is an essential regulator of heart function
MA Crackower et al.
NATURE (2002)
分享论文
